Pharma Focus Asia

Catalent Invests US$20 million to Expand in Schorndorf, Germany

Introduction:

Catalent invests US$20 million to expand its clinical supply facility. The new facility will be located in Schorndorf, Germany.

Features:

The project will increase the site's footprint  by 32,000 square feet (3,000 square metres) to increase the capacity to store and process clinical trial  materials at a controlled room temperature of 15 to 25 degrees Celsius. In addition, this expansion will add more space to install a new fully automated bottling line and a dedicated area for the Catalend FastChain® on-demand delivery service.

Moreover, the facility is well-equipped with temperature-controlled processing, storage and distribution to meet the region's growing demand for clinical delivery capacity and services, including  products requiring cold chain support.

This expansion enables to provide the much needed capacity and capabilities to the growing needs of customers.

Construction of the project is expected to be completed by 2024.

Specifications:

Name    Catalent
Type      Expansion
Budget   US$20 million
Year       2024

magazine-slider-imageCytiva - Supor Prime filtersMFA + MMA 2024CPHI China || PMEC China 2024Asia Healthcare Week 2024CPHI Korea 2024CHEMICAL INDONESIA 2024World Orphan Drug Congress Europe 2024INALAB 2024Thermo Fisher - Drug Discovery and the impact of mAbsAdvanced Therapies USA 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Cell and Gene Pharmaceutical Products ConferenceĀ 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals Conference3rd World ADC Asia 2024LogiPharma Asia 2024